Back

Age- and sex-associated cardiac features and diagnostic latency in patients with ATTR-mixed and PN phenotypes assessed in a prospective multi-national real-world study

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Sex differences in heart failure Epidemiology, Prognosis, Outcome Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Margot Davis

University of British Columbia, Vancouver (Canada)

5 More presentations in this session

Presentation thumbnail
Gender differences in long-term outcomes after acute myocardial infarction complicated by acute heart failure
Doctor Y. Horbachuk (Vinnytsa, UA)
Presentation thumbnail
Sex differences in heart failure outcomes: nationwide data from 2015 to 2023
Doctor D. Kosuta (Ljubljana, SI)
Abstract Slides Video
Presentation thumbnail
Sex differences in presentation, diagnostics, and outcomes across cardiomyopathies: insights from a prospective cohort.
Doctor C. Nordberg Backelin (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Community pharmacy as the main vaccinator in remotely monitored heart failure patients: sex- and age-related differences in vaccination pathways.
Professor N. Girerd (Nancy, FR)
Abstract Slides Video
Presentation thumbnail
Sex differences in adherence to guideline-directed medical therapy and their prognostic impact in HFrEF: insights from the KorAHF III registry
Doctor M. Kim (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Sex differences in heart failure

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Presentation
Wild-type transthyretin cardiac amyloidosis: sex differences in prevalence, phenotype, and prognosis
thumbnail
Congress Presentation
Sex-based differences in phenotypic expression and prognosis of transthyretin cardiac amyloidosis associated with the Val122Ile variant
thumbnail
Congress Session
Amyloid cardiomyopathy: epidemiology, diagnosis, prognostic and treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources